Page 95 - 南京医科大学学报自然科学版
P. 95

第42卷第1期                  狄世豪,刘 冲,宋国新,等. 腺泡状软组织肉瘤临床病理学观察[J].
                  2022年1月                     南京医科大学学报(自然科学版),2022,42(01):085-089                       · 89  ·


               [14] TANABE K,NAKAMURA S,HYUGA T,et al. Pediatric       2020,251(4):365-377
                    primary alveolar soft part sarcoma of the bladder[J].  [18] COHEN J W,WIDEMANN B C,DERDAK J,et al. Cedi⁃
                    Case Rep Urol,2018,2018:1284756                    ranib phase⁃II study in children with metastatic alveolar
               [15] SHARAIN R F,GOWN A M,GREIPP P T,et al. Immu⁃       soft ⁃ part sarcoma (ASPS)[J].Pediatr Blood Cancer,
                    nohistochemistry for TFE3 lacks specificity and sensitivi⁃  2019,66(12):e27987
                    ty in the diagnosis of TFE3⁃rearranged neoplasms:a com⁃  [19] 赵丽娜,黄亚冰,高利昆,等. 腺泡状软组织肉瘤7例临
                    parative,2⁃laboratory study[J]. Hum Pathol,2019,87:  床病理分析[J].临床与实验病理学杂志,2018,34(8):
                    65-74                                              896-899
               [16] ISHIGURO N,YOSHIDA H. ASPL ⁃ TFE3 oncoprotein  [20] TANAKA M,HOMME M,YAMAZAKI Y,et al. Modeling
                     regulates cell cycle progression and induces cellular se⁃  alveolar soft part sarcoma unveils novel mechanisms of
                     nescence by up⁃regulating p21[J]. Neoplasia,2016,18  metastasis[J]. Cancer Res,2017,77(4):897-907
                    (10):626-635                                 [21] 伍金凤,陈灵凤,秦亚萍,等. 肺原发性腺泡状软组织肉
               [17] WANG X T,FANG R,ZHANG R S,et al. Malignant mel⁃    瘤1例[J]. 临床与实验病理学杂志,2019,35(3):375-
                    anotic Xp11 neoplasms exhibit a clinicopathologic spec⁃  376
                    trum and gene expression profiling akin to alveolar soft                [收稿日期] 2020-11-17
                    part sarcoma:a proposal for reclassification[J]. J Pathol,                  (本文编辑:蒋 莉)






                



               (上接第57页)

                    predicts poor clinical outcome in B⁃cell chronic lympho⁃  [18] MOREAU C,LIU Q,GRAEFF R,et al. CD38 structure⁃
                    cytic leukemia[J]. Leuk Lymphoma,2001,42:109-114   based inhibitor design using the n1⁃cyclic inosine5′⁃di⁃
               [16] RICHES J C,O’DONOVAN C J,KINGDON S J,et al.        phosphate ribose template[J]. PLoS One,2013,8(6):
                    Trisomy 12 chronic lymphocytic leukemia cells exhibit  e66247
                    upregulation of integrin signaling that is modulated by  [19] GLASSMANA B,HAYES K J. The value of fluorescence
                    notchmutations[J]. Blood,2014,123(26):4101-4110    in situ hybridization in the diagnosis and prognosis of
               [17] BRACHTL G,HOFBAUER J P,GREIL R,et al. The          chronic lymphocytic leukemia[J]. Cancer Genet Cytogen⁃
                    pathogenic relevance of the prognostic markers CD38 and  et,2005,158(1):88-91
                    CD49d in chronic lymphocytic leukemia[J]. Ann Hema⁃                     [收稿日期] 2021-02-26
                    tol,2014,93(3):361-374                                                      (本文编辑:陈汐敏)
   90   91   92   93   94   95   96   97   98   99   100